Art TherapymandalaNCT07496268
The Effect of Art-based Mandala Intervention
A study testing Mnadala coloring in people with Art Therapy and Mandala Coloring, run by Istanbul Medeniyet University at 1 site in Turkey (Türkiye).
Trial summary
Objective This study aimed to investigate the effect of art-based mandala intervention on anger and death anxiety in older adults residing in a nursing home. Methods A randomized controlled experimental study with 80 participants (experimental group n = 40; control group n = 40) was conducted. Read more about this study
- Who is it for?
- Ages 65 years and older
- Conditions the study is for
- Art Therapy, Mandala Coloring, Anger
- What is being tested?
- Mnadala coloring
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 80 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 12 Apr 2024to 23 Jun 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- No healthy volunteers
- Older adult
Who may be able to join
- residing in the nursing home, being 65 years of age or older, scoring 24 or more points on the Mini-Mental State Examination, having no psychiatric diagnoses, not currently participating in courses related to coping with anxiety and stress, and voluntarily agreeing to participate in the study.
Who cannot join
- out of the inclusion criteria
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Istanbul Medeniyet University
Istanbul, Kartal, 34862
About this study
Official title: The Effect of Art-based Mandala Intervention on Death Anxiety and Anger Levels in Elderly Adults Living in Nursing Homes: A Randomized Controlled Study
Objective This study aimed to investigate the effect of art-based mandala intervention on anger and death anxiety in older adults residing in a nursing home.
Methods A randomized controlled experimental study with 80 participants (experimental group n = 40; control group n = 40) was conducted. The experimental group participated in mandala coloring three times a week for 12 weeks. Data were collected using a descriptive form, a death anxiety scale, and the State-Trait Anger Expression Inventory.
Read the detailed description
Objective This study aimed to investigate the effect of art-based mandala intervention on anger and death anxiety in older adults residing in a nursing home.
Methods A randomized controlled experimental study with 80 participants (experimental group n = 40; control group n = 40) was conducted. The experimental group participated in mandala coloring three times a week for 12 weeks. Data were collected using a descriptive form, a death anxiety scale, and the State-Trait Anger Expression Inventory.
- Conditions
- Art Therapy, Mandala Coloring, Anger, Death Anxiety, Elderly
- Being tested
- Mnadala coloring, Control
- Medical subject headings
- Necrophobia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Mnadala coloringBehavioural
Mnadala coloring
ControlBehavioural
do nothing
| Study group | Role | What they receive |
|---|---|---|
| Mandala | Experimental | Mandala Receives: Behavioral: Mnadala coloring |
| Control | Other | do nothing Receives: Behavioral: Control |
What is being measured
The primary outcome is the main question the study is designed to answer.
Death Anxiety Scale
Death Anxiety Scale: The validity and reliability study of the Turkish version of the "Death Anxiety Scale". The scale 15-item true/false scale measures anxiety and fear related to one's own death and mortality risk. Each "yes" response to the first nine items and each "no" response to the remaining six items receives a score of "1." The total score indicates the level of death anxiety. The maximum possible score is 15, with scores interpreted as follows: 0-4 (mild), 5-9 (moderate), 10-14 (severe), and 15 (panic).
Measured: Baseline and 12 weeks follow-up
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Mar 2026
- Study start12 Apr 2024
- Primary completion24 Apr 2025
- Study completion23 Jun 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Art TherapyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Model description
- This randomized controlled trial involved older adults who engaged in mandala coloring three times a week for 12 weeks. Based on the assumption that mandala coloring could reduce thanatophobia (fear of death) levels by 30 % (effect size dz: 0.5), a sample size of at least 35 participants per group was determined using a power of 95 %, alpha of 0.05, and beta of 0.20. Anticipating potential attrition, 100 participants were initially enrolled. After applying exclusion criteria, the study was completed with 80 participants (experimental group n = 40; control group n = 40). The researchers created a flow diagram based on CONSORT guidelines. Due to the nature of the intervention, blinding of the participants was not possible. Upon study completion, an independent statistician, blinded to group allocation, analyzed the data and reported the findings.
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 80 participants (actual)
Sponsor and investigators
- Lead sponsor
- Istanbul Medeniyet University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Berna Dincer, Istanbul Medeniyet University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07496268
- Sponsor's protocol ID
- ıstanbulımu IMU-2026-BD
- Acronym
- mandala
- Status last verified
- Mar 2026
- First submitted
- 11 Mar 2026
- Last updated
- 27 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 27 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Art-based Mandala Intervention on Death Anxiety and Anger Levels in Elderly Adults Living in Nursing Homes: A Randomized Controlled Study
- ClinicalTrials.gov ID
- NCT07496268
- Acronym / sponsor ID
- mandala / ıstanbulımu IMU-2026-BD
- Conditions
- Art Therapy, Mandala Coloring, Anger, Death Anxiety, Elderly
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 80 participants (actual)
- Lead sponsor
- Istanbul Medeniyet UniversityUniversity, hospital or other
- Study start
- 12 Apr 2024 (actual)
- Primary completion
- 24 Apr 2025 (actual)
- Study completion
- 23 Jun 2025 (actual)
- First posted
- 27 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Objective This study aimed to investigate the effect of art-based mandala intervention on anger and death anxiety in older adults residing in a nursing home.
Methods A randomized controlled experimental study with 80 participants (experimental group n = 40; control group n = 40) was conducted. The experimental group participated in mandala coloring three times a week for 12 weeks. Data were collected using a descriptive form, a death anxiety scale, and the State-Trait Anger Expression Inventory.
Detailed description
Objective This study aimed to investigate the effect of art-based mandala intervention on anger and death anxiety in older adults residing in a nursing home.
Methods A randomized controlled experimental study with 80 participants (experimental group n = 40; control group n = 40) was conducted. The experimental group participated in mandala coloring three times a week for 12 weeks. Data were collected using a descriptive form, a death anxiety scale, and the State-Trait Anger Expression Inventory.
Study design
- Primary purpose
- Prevention
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
- Model description
- This randomized controlled trial involved older adults who engaged in mandala coloring three times a week for 12 weeks. Based on the assumption that mandala coloring could reduce thanatophobia (fear of death) levels by 30 % (effect size dz: 0.5), a sample size of at least 35 participants per group was determined using a power of 95 %, alpha of 0.05, and beta of 0.20. Anticipating potential attrition, 100 participants were initially enrolled. After applying exclusion criteria, the study was completed with 80 participants (experimental group n = 40; control group n = 40). The researchers created a flow diagram based on CONSORT guidelines. Due to the nature of the intervention, blinding of the participants was not possible. Upon study completion, an independent statistician, blinded to group allocation, analyzed the data and reported the findings.
| Arm | Type | Receives |
|---|---|---|
| Mandala | Experimental | Behavioral: Mnadala coloringMandala |
| Control | Other | Behavioral: Controldo nothing |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
Key inclusion criteria (1 listed)
- residing in the nursing home, being 65 years of age or older, scoring 24 or more points on the Mini-Mental State Examination, having no psychiatric diagnoses, not currently participating in courses related to coping with anxiety and stress, and voluntarily agreeing to participate in the study.
Key exclusion criteria (1 listed)
- out of the inclusion criteria
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Mnadala coloringMnadala coloring | Behavioural | Mandala |
| Controldo nothing | Behavioural | Control |
Primary outcome
Death Anxiety Scale
Time frame: Baseline and 12 weeks follow-up
Death Anxiety Scale: The validity and reliability study of the Turkish version of the "Death Anxiety Scale". The scale 15-item true/false scale measures anxiety and fear related to one's own death and mortality risk. Each "yes" response to the first nine items and each "no" response to the remaining six items receives a score of "1." The total score indicates the level of death anxiety. The maximum possible score is 15, with scores interpreted as follows: 0-4 (mild), 5-9 (moderate), 10-14 (severe), and 15 (panic).
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Mar 2026.
- Individual participant dataSharing planned: No
Related trials for Art Therapy
Not yet recruiting
Mandala Coloring in Late Pregnancy
Pregnancy, Anxiety
Active, not recruiting
Virtual Art Therapy Assisted Re-Integration to Improve Biopsychosocial Outcomes in Adolescent and Young Adult Cancer Survivors, AVATARS Trial
Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm
Active, not recruiting
Targeting Social Function in Anxiety and Eating Disorders
Eating Disorders, Anorexia Nervosa
RecruitingPhase 3
A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)
Infertility
Not yet recruitingPhase 1
A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection
HIV-1-infection
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Mnadala coloring in people with Art Therapy and Mandala Coloring, run by Istanbul Medeniyet University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 27 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Death Anxiety Scale (time frame: Baseline and 12 weeks follow-up). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2026.